Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Gentronix – genotoxicity assays

Gentronix – genotoxicity assays

Posted on by

Gentronix is biotech innovation and service company specialized in early screening, mechanistic follow-up and regulatory genotoxicity assays.

Gentronix – genotoxicity assays

Gentronix
Continue reading →

Posted in Biotech Companies, Biotech Companies UK, Biotech Companies USA | Tagged Blue Screen HC, BlueScreen HC, BlueScreenHC, cytotoxic, cytotoxicity, drug development, drug discovery, early screening, genotoxic, genotoxic hazard, genotoxicity, genotoxicity assays, Gentronix, Gentronix - genotoxicity assays, Green Screen HC, GreenScreen HC, GreenScreenHC, John Nicholson, John Yates, mechanistic follow-up, regulatory genotoxicity assay, regulatory genotoxicity assays, Richard Walmsley, Steve Beasley

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress